Product logins

Find logins to all Clarivate products below.


This folder covers DRG’s Company & Drugs (C&D) data for Anti-infective which include market forecast (US, ROW and Global) and analysis on drug profile, drug group and therapy area.

Related Market Assessment Reports

Report
Biosimilars | Target Product Profile Simulator | Immunology | 2020
Abstract here
Report
Biosimilars | Target Product Profile Simulator | Oncology | 2020
Abstract here
Report
Non-Small-Cell Lung Cancer | Unmet Need | US/EU5 | 2020
Metastatic squamous non-small-cell lung cancer (NSCLC) is an aggressive form of lung cancer with poor survival outcomes. First-line treatment is limited to chemotherapy or immune checkpoint…
Report
Myasthenia Gravis – Epidemiology – Asia-Pacific
DRG Epidemiology’s coverage of Myasthenia Gravis comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of Myasthenia Gravis for each…
Report
Myasthenia Gravis – Epidemiology – Middle East & Africa
DRG Epidemiology’s coverage of Myasthenia Gravis comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of Myasthenia Gravis for each…